PharmaJet and Diomics partner on SARS-CoV-2 immune response monitoring
GOLDEN, Colo. – Aug. 29, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, today announced that shipping has begun for the quadrivalent influenza vaccine for needle-free delivery with the PharmaJet Stratis® device for the 2017-18 influenza season.
“Adding a quadrivalent influenza vaccine to the already available trivalent vaccine offering with our Needle-free delivery means healthcare providers and patients now have a choice of vaccines for the upcoming flu season,” said Ron Lowy, PharmaJet Chairman and CEO. “Not only does Needle-free offer an alternative for those 25% of adults that fear needles(1), but it also gives pharmacies and flu clinic providers a way to differentiate their flu immunization program, and a way to drive increased immunization rates and store traffic.”
PharmaJet offers the only Needle-free delivery system cleared by the FDA for administration of inactivated influenza vaccines.
Refer to Instructions for Use to ensure safe injections and to review risks.
(1) Survey of the prevalence of immunization non-compliance due to needle fears in children and adults.” Taddio A, Ipp M, Thivakaran S, et al. Vaccine 2012; 30;4807-4812 Web. https://dx.doi.org/10.1016/j.vaccine.2012.05.011
Related posts